NVP-BEZ235, a dual inhibitor of PI3K and mTOR, induces MAPK phosphorylation in HER2 positive cells

被引:0
|
作者
Serra, Violeta [1 ]
Eichhorn, Pieter [1 ]
Scaltriti, Maurizio [1 ]
Prudkin, Ludmila [1 ]
Rodriguez, Olga [1 ]
Guzman, Marta [1 ]
Baselga, Jose [1 ]
机构
[1] Vall dHebron Inst Oncol, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-52
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Radiosensitization by the Dual PI3K/mTOR inhibitor NVP-BEZ235
    Cerniglia, George J.
    Karar, Jayashree
    Koumenis, Constantinos
    Maity, Amit
    CANCER RESEARCH, 2012, 72
  • [2] Radiosensitization by the Dual PI3K/mTOR Inhibitor NVP-BEZ235
    Maity, A.
    Cerniglia, G. J.
    Karar, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S84 - S85
  • [3] SYNTHESIS AND PROCESS OPTIMIZATION OF PI3K/MTOR DUAL INHIBITOR NVP-BEZ235
    Xu, T. S.
    Lei, F.
    Tao, H.
    Li, J. Q.
    Zhang, Z. W.
    Wang, L. X.
    Xu, S.
    Zheng, P. W.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 31 - 31
  • [4] The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells
    Li, Chuntuan
    Xin, Pengliang
    Xiao, Huifang
    Zheng, Yan
    Huang, Yuanling
    Zhu, Xiongpeng
    CANCER CELL INTERNATIONAL, 2015, 15
  • [5] The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells
    Chuntuan Li
    Pengliang Xin
    Huifang Xiao
    Yan Zheng
    Yuanling Huang
    Xiongpeng Zhu
    Cancer Cell International, 15
  • [6] The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma
    Bhende, P. M.
    Park, S. I.
    Lim, M. S.
    Dittmer, D. P.
    Damania, B.
    LEUKEMIA, 2010, 24 (10) : 1781 - 1784
  • [7] The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma
    P M Bhende
    S I Park
    M S Lim
    D P Dittmer
    B Damania
    Leukemia, 2010, 24 : 1781 - 1784
  • [8] Inhibition of Autophagy as a Strategy to Augment Radiosensitization by the Dual PI3K/mTOR Inhibitor NVP-BEZ235
    Maity, A.
    Cerniglia, G. J.
    Karar, J.
    Koumenis, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S127 - S127
  • [9] Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
    Lin, Shu-Fu
    Huang, Yu-Yao
    Lin, Jen-Der
    Chou, Ting-Chao
    Hsueh, Chuen
    Wong, Richard J.
    PLOS ONE, 2012, 7 (10):
  • [10] Radiation Sensitization of Head and Neck Tumor Cells using the dual PI3K/mTOR Inhibitor NVP-BEZ235
    Balzer, V.
    Subtil, F.
    Dikomey, E.
    Engenhart-Cabillic, R.
    Schoetz, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S233 - S233